TOP > 外国特許検索 > THERAPEUTIC AGENT FOR COGNITION DISORDER INDUCED BY AMYLOID β-PROTEIN

THERAPEUTIC AGENT FOR COGNITION DISORDER INDUCED BY AMYLOID β-PROTEIN

外国特許コード F160008820
整理番号 (S2015-0044-N0)
掲載日 2016年8月10日
出願国 世界知的所有権機関(WIPO)
国際出願番号 2015JP079120
国際公開番号 WO 2016060190
国際出願日 平成27年10月15日(2015.10.15)
国際公開日 平成28年4月21日(2016.4.21)
優先権データ
  • 特願2014-211671 (2014.10.16) JP
発明の名称 (英語) THERAPEUTIC AGENT FOR COGNITION DISORDER INDUCED BY AMYLOID β-PROTEIN
発明の概要(英語) The present invention addresses the problem of providing a therapeutic agent for cognition disorders induced by amyloid β-protein, the therapeutic agent functioning by a mechanism in which amyloid β-protein is involved but which is different from conventional mechanisms. This medicinal composition, which is for the treatment of cognition disorders induced by amyloid β-protein, comprises a pharmaceutically acceptable carrier and a therapeutically effective amount of either the peptide according to the invention or a pharmaceutically acceptable ester, amide, prodrug, or salt thereof.
特許請求の範囲(英語) [claim1]
1. (A) below the - (e) from the group which consists of to in each case is chosen the peptide of statement:
(A) The peptide which includes the amino acid arrangement which is shown in SEQ ID NO 1;
(B) The peptide which consists of the amino acid arrangement which is shown in SEQ ID NO 1;
(C) At the time of amino acid arranging of SEQ ID NO 1, the peptide which possesses the curative effect for the acknowledgment obstacle where the 1-3 amino acid is deficient, substitution and insertion, and/or consists of the amino acid arrangement which is added, is induced at the same time by the amyloid I protein;
And
(D) Vis-a-vis the amino acid arrangement of SEQ ID NO 1, the peptide which possesses the curative effect for the acknowledgment obstacle which possesses the amino acid arrangement which possesses the identity of 90% or more, is induced at the same time by the amyloid I protein.
[claim2]
2. It consists of the amino acid arrangement which is shown in SEQ ID NO 2, in claim 1 the peptide of statement.
[claim3]
3. It consists of the amino acid arrangement which is shown in SEQ ID NO 3, in claim 1 the peptide of statement.
[claim4]
4. It is synthetic peptide, in claim 1 the peptide of statement.
[claim5]
5. In regard to remedy the peptide or that medicine approved possible ester, amide, the professional drug or the salt of statement and the approved possible carrier is included in claim 1 of the effective quantity medicine, the medicine composition for remedying the acknowledgment obstacle which is induced by the amyloid I protein.
[claim6]
6. It is something which inside intraperitoneal is prescribed, in claim 5 the composition of statement.
[claim7]
7. Section it is something which is prescribed, in claim 5 the composition of statement.
[claim8]
8. Another Alzheimer's disease remedy medicine it is jointly used, in claim 5 the composition of statement.
[claim9]
9. The peptide or that medicine in claim 1 in order to use for the remedy of the acknowledgment obstacle which is induced by the amyloid I protein approved possible ester, amide, the professional drug or the salt of statement.
[claim10]
10. In regard to remedy the peptide or that medicine approved possible ester, amide, the professional drug or the salt of statement the fact that it prescribes to the patient who needs remedy is included in claim 1 of the effective quantity, remedy method of the acknowledgment obstacle which is induced by the amyloid I protein.
  • 出願人(英語)
  • ※2012年7月以前掲載分については米国以外のすべての指定国
  • HOKKAIDO UNIVERSITY
  • OKAYAMA UNIVERSITY
  • 発明者(英語)
  • SUZUKI TOSHIHARU
  • BAN SAORI
  • INOUE TSUYOSHI
国際特許分類(IPC)
指定国 National States: AE AG AL AM AO AT AU AZ BA BB BG BH BN BR BW BY BZ CA CH CL CN CO CR CU CZ DE DK DM DO DZ EC EE EG ES FI GB GD GE GH GM GT HN HR HU ID IL IN IR IS JP KE KG KN KP KR KZ LA LC LK LR LS LU LY MA MD ME MG MK MN MW MX MY MZ NA NG NI NO NZ OM PA PE PG PH PL PT QA RO RS RU RW SA SC SD SE SG SK SL SM ST SV SY TH TJ TM TN TR TT TZ UA UG US UZ VC VN ZA ZM ZW
ARIPO: BW GH GM KE LR LS MW MZ NA RW SD SL SZ TZ UG ZM ZW
EAPO: AM AZ BY KG KZ RU TJ TM
EPO: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
OAPI: BF BJ CF CG CI CM GA GN GQ GW KM ML MR NE SN ST TD TG
ライセンスをご希望の方、特許の内容に興味を持たれた方は、下記までご連絡ください

PAGE TOP

close
close
close
close
close
close